Amgen to Acquire Chemocentryx for $4 Billion in Cash
Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Serious Autoimmune Disease Tavneos Adds to Amgen's Decades-Long Leadership in Inflammation and Nephrology THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4,... Biopharmaceuticals, Mergers & Acquisitions Amgen, ChemoCentryx, TAVNEOS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 4, 2022 Category: Pharmaceuticals Source Type: news

Depression, anxiety, substance misuse and self-harm in children and young people with rare chronic liver disease - Chang WH, Foster GR, Kelly DA, Lai AG.
The burden of mental illness in young people with chronic liver disease is not known. In this population cohort study in England, we identified 358 individuals (aged ≤25 years) diagnosed with autoimmune hepatitis or liver disease related to cystic fibros... (Source: SafetyLit)
Source: SafetyLit - August 1, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

STELARA ® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, August 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of pediatric patients six years of age and older with active psoriatic arthritis (PsA). This rare disease that resembles adult PsA affects five to eight percent of children and adolescents with chronic inflammatory arthritis.*1-7 Two of the four indications for STELARA now include pediatric patients, further expanding its treatment profile since the first approval in 2009 for adults living with moderate...
Source: Johnson and Johnson - August 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

New lupus treatments offer a better chance for remission
Yale Medicine experts explain the autoimmune disease and discuss new drugs that are allowing doctors to offer more patients a better chance of remission. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 29, 2022 Category: Universities & Medical Training Source Type: news

Doctors with Disabilities Push for Change as Long COVID Affects Their Workforce
As the third year of the pandemic continues, doctors with disabilities are pushing the medical field to improve its treatment of disabled health professionals. An increasing number of people have Long Covid and need accommodations at work, and in the health care workforce, their ability to stay in their profession will be critical to helping patients also suffering from the little-understood condition. One in five American adults who has been infected with COVID-19 has some lingering symptoms that can be considered Long COVID, the Centers for Disease Control and Prevention found this spring. While symptoms vary widely, Lon...
Source: TIME: Health - July 27, 2022 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 feature uspoliticspolicy Source Type: news

Mayo Clinic Q and A:  Is a lectin-free diet beneficial?
DEAR MAYO CLINIC: A friend of mine continues to speak highly about the health benefits of a diet where people eliminate lectins. She says it helped her lose weight and reduced her arthritis pain. What are lectins, and can a lectin-free diet cure autoimmune diseases and prevent other health problems? ANSWER: Lectins are naturally occurring proteins that are found in all foods, but they are most concentrated in certain plants. Lectins serve a protective function for plants… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 27, 2022 Category: Databases & Libraries Source Type: news

Mystery hepatitis cases in kids linked to unexpected viral suspect
Starting in April, young children in the United Kingdom and other countries suffering from mysterious cases of acute liver inflammation began to attract scientific —and media—attention. Most would recover, some after liver transplants, but a few died. Physicians could find no evidence in the children of the standard viruses that caused their hepatitis, but researchers homed in on an unexpected suspect: adenovirus, a family of cold-causing viruses common in kids. Now, a sweeping genetic search of these patients instead implicates another virus,  one thought to be completely harmless. In two independent,...
Source: ScienceNOW - July 25, 2022 Category: Science Source Type: news

Differential effects of an experimental model of prolonged sleep disturbance on inflammation in healthy females and males - Besedovsky L, Dang R, Engert LC, Goldstein MR, Devine JK, Bertisch SM, Mullington JM, Simpson N, Haack M.
Sleep disturbances, including disrupted sleep and short sleep duration, are highly prevalent and are prospectively associated with an increased risk for various widespread diseases, including cardiometabolic, neurodegenerative, chronic pain, and autoimmune... (Source: SafetyLit)
Source: SafetyLit - July 25, 2022 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: a systematic review and meta-analysis - Peres DS, Rodrigues P, Viero FT, Frare JM, Kudsi SQ, Meira GM, Trevisan G.
Multiple sclerosis (MS) is a chronic neurodegenerative and autoimmune disease. Motor, sensory and cognitive deficits in MS are commonly accompanied by psychiatric disorders. Depression and anxiety affect the quality of life of MS patients, and the treatmen... (Source: SafetyLit)
Source: SafetyLit - July 25, 2022 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
BOSTON, July 25, 2022 -- (Healthcare Sales & Marketing Network) -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases, tod... Biopharmaceuticals, Personnel HotSpot Therapeutics, allosteric medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 25, 2022 Category: Pharmaceuticals Source Type: news

Science Saturday: Lupus rates increasing, communities of color especially vulnerable
New research led by Mayo Clinic shows that more people are being diagnosed with lupus than in the past, while risks of severity and death remain the same. The study is published in BMJ Annals of the Rheumatologic Diseases. Lupus is a chronic autoimmune disorder that causes inflammation and pain throughout the body. Most common in women (9 of 10 diagnosed cases); it attacks both joints and organs – including the skin. "In our study, we confirmed that in… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - July 23, 2022 Category: Research Source Type: news

Population-Based Study Looks at Comorbidities in Meniere Disease
FRIDAY, July 22, 2022 -- Contrary to the results of previous studies, autoimmune and metabolic disorders may not be associated with the onset of Meniere disease, according to a study recently published in Scientific Reports. Min Hee Kim, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2022 Category: Pharmaceuticals Source Type: news

Multiple Sclerosis Patients on the Most Effective Ways Doctors Can Treat Their Condition
Because multiple sclerosis involves nerve damage that can occur throughout the body, including brain connections, symptoms can vary widely and be progressive. That makes each patient’s journey unique, and can prompt challenges on both sides of the exam table. Here’s what eight patients with the disease wish doctors knew when it comes to helping them manage the condition more effectively. Diagnosis should be its own appointment Although Dr. Claire Warren—a 70-year-old Stonington, N.Y.–based physician—has plenty of experience treating patients with all kinds of ailments, it wasn’t until sh...
Source: TIME: Health - July 21, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

Abortion Laws Deny Treatments Needed for Autoimmune Disease Abortion Laws Deny Treatments Needed for Autoimmune Disease
Methotrexate, a first-line treatment for autoimmune diseases, is being denied to some patients since SCOTUS overturned Roe v Wade.Medscape Blogs (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 21, 2022 Category: Infectious Diseases Tags: Infectious Diseases Blog Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Basel, 21 July 2022Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follic...
Source: Roche Media News - July 21, 2022 Category: Pharmaceuticals Source Type: news